Epinastine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H15N3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GFM415S5XL, chemically known as 9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride but more generally known as epinastine hydrochloride, which bears US NIH Compound Identifier 157313. European Medicines Agency schedules Epinastine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01910MIG. Most nations, for tariff and trade purposes, schedule epinastine hydrochloride under HS 29339930 and SITC 51577. As of Q4 2014, EPINASTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Epinastine hydrochloride bears US NLM identifiers UMLS ID C1321612 and NCI Concept Code C47512. SMILES: C1CCC2C(C1)CC3CCCCC3N4C2CN=C4N.CL.